Navigation Links
Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013

NEW YORK, Sept. 7 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Biotechnology Pharmaceutical Market in US -2013

Biotechnology Pharmaceutical Market in US 2009-2013 report by Technavio Insights forecasts the Biotechnology Pharmaceutical market to grow at a CAGR of 7.7 percent, with Blood Modifiers accounting for the largest share of the market at 36.3 percent.

The major growth drivers include:- Increasing demand for biotechnology drugs with enhanced efficiency, safety and popularity

- Revision of regulations and standards in favour of biotechnology drugs are encouraging more companies to invest in the field

- Increasing ageing population and the prevalence of chronic and age related illnesses is also driving the demand for biotechnology pharmaceuticals

However, the market is faced with some challenges which can inhibit the growth, such as the increasing healthcare expenditure in the US. Many biotechnology pharmaceutical companies are facing cost containment pressure. Lack of technical development and expertise is an issue as these companies need to employ highly skilled medical professionals.

For the purpose of this report, the Biotechnology Pharmaceutical market refers to drugs, medicines or vaccines developed through biotechnology such as recombinant DNA technology, combinatorial chemistry, gene therapy, and monoclonal antibodies. The report analyzes Biotechnology Pharmaceutical market's recent performance and provides the US market revenue and growth rates from 2009 through to 2013. It also provides detailed market segmentation based on the type of disease the drugs are formulated to treat or based on therapeutic class. The report includes comprehensive analysis of various trends and changes taking place in the Biotechnology Pharmaceutical market in the US.

It also explains the factors influencing market growth and also inhibitors preventing their adoption. The report provides basic profiles of some of the leading vendors in the market

1. Introduction

2. Market Size and Forecast

3. Market Segmentation

4. Market Trends in Biotechnology Pharmaceutical in US

5. Market Drivers in Biotechnology Pharmaceutical in US

6. Market Challenges in Biotechnology Pharmaceutical in US

7. Vendors

8. Related Reports in this Series

List of ExhibitsExhibit 2.1: Biotechnology Pharmaceutical in US Market Size and Forecast 2009-2013 (In $billion)

Exhibit 3.1: US Biotechnology Pharmaceutical Market Segmentation -2009

To order this report:Biotechnology Industry: Biotechnology Pharmaceutical Market in US -2013

Biotechnology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds US Vaccines Market
2. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
3. Reportlinker Adds Womens Infertility - Pipeline Assessment and Market Forecasts to 2017
4. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
5. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
6. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
7. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
8. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
9. Reportlinker Adds Advances in Biopharmaceutical Technology in China
10. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
11. Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
Post Your Comments:
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper ... unless it is bound to proteins, copper is also toxic to cells. With ... Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper in the ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):